Effects of High-Fiber Diets and Macronutrient Substitution on Bloating: Findings From the OmniHeart Trial.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 24 1 2020
medline: 20 11 2020
entrez: 24 1 2020
Statut: ppublish

Résumé

To examine the effects of high-fiber, isocaloric, macronutrient substitutions on bloating. The OmniHeart study is a randomized 3-period crossover feeding trial conducted from April 2003 to June 2005. Participants were provided 3 isocaloric versions of high-fiber (∼30 g per 2,100 kcal) diet, each different in carbohydrate, protein, and unsaturated fat composition. Each feeding period lasted for 6 weeks with a 2- to 4-week washout period between diets. Participants reported the presence and severity of bloating at baseline (participants were eating their own diet) and at the end of each feeding period. One hundred sixty-four participants were included in the analysis (mean age: 53.1 years; 45% women; 55% black). The prevalence of bloating at baseline and at the end of the carbohydrate-rich, protein-rich, and unsaturated fat-rich diet period was 18%, 24%, 33%, and 30%, respectively. Compared with baseline, the relative risk of bloating for the carbohydrate-rich, protein-rich, and unsaturated fat-rich high-fiber diet was 1.34 (95% confidence interval [CI]: 0.93, 1.92), 1.78 (95% CI: 1.32, 2.40), and 1.63 (95% CI: 1.17, 2.26), respectively. The protein-rich diet increased the risk of bloating more than the carbohydrate-rich diet (relative risk = 1.40; 95% CI: 1.03, 1.88). Bloating did not significantly vary between protein-rich vs unsaturated fat-rich or unsaturated fat-rich vs carbohydrate-rich diets. Black participants compared with non-black participants had a higher risk of bloating after all 3 versions of the high-fiber OmniHeart diet (P-value for interaction = 0.012). Substitution of protein with carbohydrate may be an effective strategy to decrease bloating among individuals experiencing gastrointestinal bloating from a high-fiber diet.

Identifiants

pubmed: 31972610
doi: 10.14309/ctg.0000000000000122
pmc: PMC7056053
pii: 01720094-202001000-00008
doi:

Substances chimiques

Dietary Carbohydrates 0
Dietary Fats, Unsaturated 0
Dietary Fiber 0
Dietary Proteins 0

Banques de données

ClinicalTrials.gov
['NCT00051350']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00122

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL135273
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL141589
Pays : United States

Références

J Nutr. 2005 May;135(5):1177-82
pubmed: 15867300
World J Gastrointest Pathophysiol. 2018 Sep 29;9(2):47-58
pubmed: 30283710
Nutr Rev. 2001 May;59(5):129-39
pubmed: 11396693
Ann Intern Med. 2004 May 18;140(10):769-77
pubmed: 15148063
Nat Commun. 2015 Apr 28;6:6342
pubmed: 25919227
Clin Epidemiol. 2014 Feb 04;6:71-80
pubmed: 24523597
Clin Gastroenterol Hepatol. 2009 Jan;7(1):68-72; quiz 3
pubmed: 19124113
Clin Trials. 2005;2(6):529-37
pubmed: 16422313
Am J Gastroenterol. 2017 Aug;112(8):1221-1231
pubmed: 28508867
Am J Gastroenterol. 2018 Nov;113(11):1701-1710
pubmed: 30323268
J Am Diet Assoc. 2008 Feb;108(2):257-65
pubmed: 18237574
Nutrients. 2019 Apr 25;11(4):
pubmed: 31027300
J Nutr. 1982 Jun;112(6):1133-43
pubmed: 6283045
Am J Gastroenterol. 2013 May;108(5):718-27
pubmed: 23545709
Gut. 2004 Nov;53(11):1577-82
pubmed: 15479674
Am J Gastroenterol. 2019 Jul;114(7):1109-1115
pubmed: 31206400
JAMA. 2005 Nov 16;294(19):2455-64
pubmed: 16287956
Gastroenterol Hepatol (N Y). 2011 Nov;7(11):729-39
pubmed: 22298969

Auteurs

Mingyu Zhang (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Stephen P Juraschek (SP)

Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

Lawrence J Appel (LJ)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Pankaj Jay Pasricha (PJ)

Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Edgar R Miller (ER)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Noel T Mueller (NT)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH